Christer Sederholm

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Pia Baumann, Jan Nyman, Berit Wennberg et al. · Journal of Clinical Oncology · 2009 · 844 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Christer Sederholm, Gunnar Hillerdal, Kristina Lamberg et al. · Journal of Clinical Oncology · 2005 · 215 citations · Full text

Medicine, Oncology, Pharmacology +15

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

Andreas Hermes, Bengt Bergman, Roy M. Bremnes et al. · Journal of Clinical Oncology · 2008 · 167 citations · Full text

Medicine, Oncology, Pharmacology +12

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

Pia Baumann, Jan Nyman, Giovanna Gagliardi et al. · Radiotherapy and Oncology · 2008 · 143 citations

Medicine, Oncology, Radiation Oncology +15

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

C. Manegold, Bengt Bergman, A. Chemaissani et al. · Annals of Oncology · 1997 · 114 citations · Full text

Medicine, Oncology, Pharmacology +14